UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: October 14, 2020
Accession Number: 0001193125-20-268640
Submission Type: POS AM
CIK: 0001631650
Company Name: Aimmune Therapeutics, Inc.
File Number: 333-222333